GH Secretagogues: CJC-1295 and Ipamorelin in Research

CJC-1295 and Ipamorelin are two synthetic peptides that appear together throughout the growth-hormone secretagogue research literature. This overview explains how each is described mechanistically and why researchers often study them as a pair. It is provided as educational background only; both are supplied strictly as research materials and not for human or animal use.

What Are Growth-Hormone Secretagogues?

In endocrinology research, a "secretagogue" is a substance studied for its ability to influence the secretion of another substance. Growth-hormone (GH) secretagogues are investigated in laboratory and animal models for their interaction with the signaling pathways that regulate GH release. Two broad categories appear frequently in the literature: analogues of growth-hormone-releasing hormone (GHRH) and growth-hormone-releasing peptides (GHRPs).

These pathways are a long-standing subject of basic research because GH signaling is naturally pulsatile and tightly regulated, which makes it an interesting system for studying receptor behavior and feedback control in model systems.

CJC-1295 (Mod GRF 1-29)

CJC-1295 is a synthetic analogue based on a fragment of GHRH. The "Mod GRF (1-29)" designation refers to a modified 29-amino-acid sequence engineered for greater stability than the native fragment. In research contexts it is studied as a GHRH-pathway analogue, and it is supplied lyophilized for reconstitution prior to use as a reference compound.

The variant most commonly referenced as "CJC-1295 no DAC" lacks the Drug Affinity Complex modification, which is one of the characteristics researchers consider when designing experiments around release kinetics in model systems.

Ipamorelin

Ipamorelin is a synthetic peptide categorized in the literature as a growth-hormone-releasing peptide (GHRP). It is frequently described as a selective secretagogue, and it interacts with a different receptor pathway than GHRH analogues. Like CJC-1295, it is handled as a lyophilized research material and characterized analytically before experimental use.

Why They Are Studied Together

Researchers often examine GHRH analogues and GHRPs in combination because they engage distinct but complementary signaling pathways. Studying them together in model systems allows investigators to explore how separate inputs interact within the regulatory network. This pairing is a recurring theme in the preclinical literature on pulsatile GH dynamics.

As with all such work, these are mechanistic and model-system investigations. The literature does not establish outcomes in humans, and these compounds are not approved for any therapeutic use.

Handling and Reconstitution

Both peptides are supplied lyophilized and are reconstituted with bacteriostatic water when a researcher prepares a working solution. Lyophilized material is generally stored cool or frozen and protected from light; reconstituted solutions are typically refrigerated and used within a limited window. Calculating the diluent volume for a target concentration in advance helps keep measurements consistent.

Research-Use Context

CJC-1295 and Ipamorelin offered by MedVita Wellness are sold strictly for laboratory and in vitro research use only. They are not drugs or supplements, have not been evaluated or approved by the FDA, and are not intended for human or animal consumption. Researchers are responsible for compliance with all applicable laws and institutional policies.